Transmission of relaxin and estrogens to suckling canine pups via milk and possible association with hip joint laxity

American Journal of Veterinary Research

Volumn 69, Issue 1, 2008, Pages 59-67

  Steinetz, Bernard G ^a   Williams, Alma J ^b   Lust, George ^b   Schwabe, Christian ^c   Büllesbach, Erika E ^c   Goldsmith, Laura T ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; ESTRADIOL CIPIONATE; ESTROGEN; ESTROGEN DERIVATIVE; FADROZOLE; RELAXIN;

ANIMAL EXPERIMENT; ARTICLE; BITCH; CONTROLLED STUDY; DOG DISEASE; DRUG ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; GENETIC PREDISPOSITION; HIP DYSPLASIA; JOINT LAXITY; LACTATION; MALE; MILK; MILK LEVEL; NEWBORN; NONHUMAN; PROGENY; PUPPY; SUCKLING;

ANIMALS; ANIMALS, SUCKLING; DOGS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FADROZOLE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIP DYSPLASIA, CANINE; HIP JOINT; LACTATION; LIGAMENTS; MALE; MILK; RADIOIMMUNOASSAY; RELAXIN;

ANIMALIA; CANIDAE;

EID: 38749114640     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.1.59     Document Type: Article

References (42)

1. Lust G, Geary JC, Sheffy BE. Development of hip dysplasia in dogs. Am J Vet Res 1973;34:87-91.
2. Lust G, Rendano V, Summers BA. Canine hip dysplasia: concepts and diagnosis. J Am Vet Med Assoc 1985;187:638-640.
3. Orthopedic Foundation for Animals. Hip dysplasia statisics. Available at: www.offa.org/hipstatbreed.html. December 7, 2007.
4. Lust G, Beilman WT, Rendano VT. A relationship between degree of laxity and synovial fluid volume in coxofemoral joints of dogs predisposed for hip dysplasia. Am J Vet Res 1980;41:55-60.
5. Lust G, Beilman WT, Dueland DJ, et al. Intra-articular volume and hip joint instability in dogs with hip dysplasia. J Bone Joint Surg 1980;62-A:576-582.
6. Olsewski JM, Lust G, Rendano VT, et al. Degenerative joint disease: multiple joint involvement in young and mature dogs. Am J Vet Res 1983;44:1300-1308.
7. Gustafsson PO, Beling CG. Estradiol-induced changes in beagle pups: effect of prenatal and postnatal adminstration. Endocrinology 1969;85:481-491.
8. Mansson J, Norberg I. Hoftledsdysplasi hos hund. Meddn bl Sver Vet For 1961;13:330-338.
9. Steinetz BG, O'Byrne EM, Butler MC, et al. Hormonal regulation of the connective tissue of the symphysis pubis. In: Bigazzi M, Greenwood FC, Gasparri F, eds. Biology of relaxin and its role in the human. Amsterdam: Excerpta Medica, 1983;71-92.
10. Musah AI, Schwabe C, Willham RL, Anderson LL. Pelvic development is affected by relaxin in three genetically selected frame sizes of beef heifers. Biol Reprod 1986;34:363-369.
11. Kawamura K, Sudo S, Kumagai J, et al. Relaxin research in the post genomic era. Ann N Y Acad Sci 2005;1041:1-7.
12. Yang S, Rembiessa B, Bullesbach EE, et al. Relaxin receptors in mice: demonstration of ligand binding in symphyseal tissues and uterine membrane fragments. Endocrinology 1992;130:179-185.
13. Pillai SB, Rockwell LC, Sherwood OD, et al. Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182,780, a specific estrogen receptor antagonist. Endocrinology 1999;140:2426-2429.
14. Schwabe C, Steinetz B, Weiss G, et al. Relaxin. Recent Prog Horm Res 1978;34:123-211.
15. Crelin ES. The development of the bony pelvis and its changes during pregnancy and parturition. Trans N Y Acad Sci 1969;31:1049-1058.
16. Dayani N, Corvol MT, Robel P, et al. Estrogen receptors in cultured rabbit articular chondrocytes: influence of age. J Steroid Biochem 1988;31:351-356.
17. Corvol MT, Carrascosa A, Tsagris L, et al. Evidence for a direct in vitro action of sex steroids on rabbit cartilage cells during skeletal growth: influence of age and sex. Endocrinology 1987; 120:1422-1429.
18. Rosner IA, Malemud CJ, Goldberg VM, et al. Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop Relat Res 1982;171:280-285.
19. Osheroff PL, Ling VT, Vandlen RL, et al. Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix and brain. J Biol Chem 1990;265:9396-9401.
20. Yan W, Wiley AW, Bathgate RAD, et al. Expression of LGR7 and LGR8 by neonatal porcine uterine tissues and transmission of milk-borne relaxin into the neonatal circulation by suckling. Endocrinology 2006;147:4303-4310.
21. Crelin ES, Levin J. The prepuberal pubic symphysis and uterus in the mouse: their response to estrogen and relaxin. Endocrinology 1955;57:730-747.
22. Andren L. Instability of the pubic symphysis and congenital dislocation of the hip in newborns. Acta Radiol 1960;54:123-128.
23. Steinetz BG, Goldsmith LT, Lust G. Plasma relaxin levels in pregnant and lactating dogs. Biol Reprod 1987;37:719-725.
24. Goldsmith LT, Lust G, Steinetz BG. Transmission of relaxin from lactating bitches to their offspring via suckling. Biol Reprod 1994;50:258-265.
25. Steinetz BG, Bullesbach EE, Goldsmith LT, et al. Use of synthetic canine relaxin to develop a rapid homologous radioimmunoassay. Biol Reprod 1996;54:1252-1260.
26. Steinetz BG, Sherwood OD, Lasano S, et al. Immuno-neutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats. J Exp Ther Oncol 2004;4:59-68.
27. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 2004;25:205-234.
28. Feng S, Bogatcheva NV, Kamat AA, et al. Genetic targeting of relaxin and Insl3 signaling in mice. Ann N Y Acad Sci 2005;1041:82-90.
29. Grovenor CE, Picciano MF, Baumrucker CR. Hormones and growth factors in milk. Endocr Rev 1992;14:710-727.
30. Koldovsky O. The potential physiological significance of milk-borne hormonally active substances for the neonate. J Mammary Gland Biol Neoplasia 1996;1:317-323.
31. Lust G, Summers BA. Early, asymptomatic stage of degenerative joint disease in canine hip joints. Am J Vet Res 1981;42:1849-1855.
32. Juniewicz PE, Oesterling JE, Walters JR, et al. Aromatase inhibition in the dog. I. Effect on serum LH, serum testosterone concentrations, testicular secretions and spermatogenesis. J Urol 1988; 139:827-831.
33. Smith GK, Biery DN, Gregor TP. New concepts of coxofemoral joint stability and the development of a clinical stress-radiographic method for quantitating hip joint laxity in the dog. J Am Vet Med Assoc 1990;196:59-70.
34. Lust G, Williams AJ, Burton-Wurster N, et al. Joint laxity and its association with hip dysplasia in Labrador retrievers. Am J Vet Res 1993;154:1990-1999.
35. Steinetz BG, Beach VL, Kroc RL, et al. Bioassay of relaxin using a reference standard: a simple and reliable method utilizing direct measurement of interpubic formation in mice. Endocrinology 1960;67:102-115.
36. Cossum PA, Hill DE, Bailey JR, et al. Transplacental passage of a human relaxin administered to rhesus monkeys. J Endocrinol 1991;130:339-345.
37. Steinetz BG. Chapter 19. Secretion and function of ovarian estrogens. In: Greep RO, ed. Handbook of physiology. Section 7. Volume II: endocrinology. Bethesda, Md: American Physiological Society, 1973;439-460.
38. Cañez MS, Lee KJ, Olive DL. Progestagens and estrogens. Infertil Reprod Med Clin North Am 1992;3:59-78.
39. Demers LM, Melby JC, Wilson TE, et al. The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis. J Clin Endocrinol Metab 1990;70:1162-1166.
40. Slight SH, Chilakamarri VK, Nasr S, et al. Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Mol Cell Biochem 1998;189:47-54.
41. Lust G, Williams AJ, Burton-Wurster N, et al. Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups. Am J Vet Res 1992;53:1836-1843.
42. Steinetz BG, Lust G. Inhibition of relaxin-induced pubic symphyseal "relaxation" in guinea pigs by glycosaminoglycan polysulfates and pentosan sulfate. Agents Actions 1994;42:74-80.